13. BIOSIMILAR

♤ The term biosimilar refers to products that are marketed after expiration of patents, which are claimed to have similar properties to existing biologic products. Due to the complexity of biologics, a product can only be made that is similar, but not identical.

♤ Biosimilars are generic impersonations (although not identical copies) of biotech drugs.

♤ Manufacturing processes for biologics differ greatly from the manufacturing processes for small molecule drugs.